Rational design of biased G protein-coupled receptor agonists.

IF 3 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Molecular Pharmacology Pub Date : 2025-12-01 Epub Date: 2025-11-19 DOI:10.1016/j.molpha.2025.100089
Vsevolod V Gurevich
{"title":"Rational design of biased G protein-coupled receptor agonists.","authors":"Vsevolod V Gurevich","doi":"10.1016/j.molpha.2025.100089","DOIUrl":null,"url":null,"abstract":"<p><p>Activation of most G protein-coupled receptors (GPCRs) initiates several branches of signaling. The consequences of some of these can be therapeutically beneficial, whereas others may cause unwanted side effects. Therefore, search for ligands biasing receptor signaling toward desired directions and away from undesired ones is increasingly popular. Currently, the field is focusing on G protein versus arrestin dichotomy. Arrestin binding to most GPCRs critically depends on receptor phosphorylation by GPCR kinases (GRKs). Existing data suggest that to bias signaling for or against arrestin-mediated branches one needs to enhance or reduce, respectively, the propensity of the receptor to recruit GRKs and become phosphorylated. As GRKs are gatekeepers for arrestin-mediated signaling, rational design of biased ligands should be based on the comparison of receptor complexes with G proteins with the structures of GPCRs bound to GRKs rather than arrestins. The same GPCR may engage distinct GRK subtypes differently, establishing an additional layer of bias. SIGNIFICANCE STATEMENT: Because arrestin binding to G protein-coupled receptors (GPCRs) requires prior receptor phosphorylation, GPCR-GPCR kinase complexes, not GPCR complexes with arrestins, should be compared to GPCR-G protein complexes to guide the design of G protein- and arrestin-biased ligands.</p>","PeriodicalId":18767,"journal":{"name":"Molecular Pharmacology","volume":"107 12","pages":"100089"},"PeriodicalIF":3.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12799398/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.molpha.2025.100089","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Activation of most G protein-coupled receptors (GPCRs) initiates several branches of signaling. The consequences of some of these can be therapeutically beneficial, whereas others may cause unwanted side effects. Therefore, search for ligands biasing receptor signaling toward desired directions and away from undesired ones is increasingly popular. Currently, the field is focusing on G protein versus arrestin dichotomy. Arrestin binding to most GPCRs critically depends on receptor phosphorylation by GPCR kinases (GRKs). Existing data suggest that to bias signaling for or against arrestin-mediated branches one needs to enhance or reduce, respectively, the propensity of the receptor to recruit GRKs and become phosphorylated. As GRKs are gatekeepers for arrestin-mediated signaling, rational design of biased ligands should be based on the comparison of receptor complexes with G proteins with the structures of GPCRs bound to GRKs rather than arrestins. The same GPCR may engage distinct GRK subtypes differently, establishing an additional layer of bias. SIGNIFICANCE STATEMENT: Because arrestin binding to G protein-coupled receptors (GPCRs) requires prior receptor phosphorylation, GPCR-GPCR kinase complexes, not GPCR complexes with arrestins, should be compared to GPCR-G protein complexes to guide the design of G protein- and arrestin-biased ligands.

偏置G蛋白偶联受体激动剂的合理设计。
大多数G蛋白偶联受体(gpcr)的激活启动了几个信号传导分支。其中一些结果在治疗上是有益的,而另一些则可能导致不必要的副作用。因此,寻找使受体信号偏向所需方向而远离不需要方向的配体越来越受欢迎。目前,该领域的重点是G蛋白与阻滞蛋白的二分法。阻滞蛋白与大多数GPCR的结合严重依赖于GPCR激酶(GRKs)的受体磷酸化。现有数据表明,要使信号偏向于支持或反对抑制蛋白介导的分支,需要分别增强或减少受体招募grk和磷酸化的倾向。由于GRKs是阻滞蛋白介导的信号传导的守门人,合理设计偏配体应该基于与G蛋白结合的受体复合物与与GRKs结合的gpcr结构的比较,而不是与阻滞蛋白结合的gpcr结构的比较。相同的GPCR可能以不同的方式参与不同的GRK亚型,从而建立了额外的偏见层。意义声明:由于抑制蛋白与G蛋白偶联受体(GPCR)的结合需要事先的受体磷酸化,因此应该将GPCR-GPCR激酶复合物而不是GPCR与抑制蛋白的复合物与GPCR-G蛋白复合物进行比较,以指导G蛋白和抑制蛋白偏配体的设计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Pharmacology
Molecular Pharmacology 医学-药学
CiteScore
7.20
自引率
2.80%
发文量
50
审稿时长
3-6 weeks
期刊介绍: Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include: Molecular Signaling / Mechanism of Drug Action Chemical Biology / Drug Discovery Structure of Drug-Receptor Complex Systems Analysis of Drug Action Drug Transport / Metabolism
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书